KEGG   PATHWAY: cfr05200
Entry
cfr05200                    Pathway                                
Name
Pathways in cancer - Camelus ferus (Wild Bactrian camel)
Class
Human Diseases; Cancer: overview
Pathway map
cfr05200  Pathways in cancer
cfr05200

Organism
Camelus ferus (Wild Bactrian camel) [GN:cfr]
Gene
102508122  DCC; netrin receptor DCC [KO:K06765]
102520133  CASP3; caspase-3 [KO:K02187] [EC:3.4.22.56]
102519816  CASP9; caspase-9 isoform X1 [KO:K04399] [EC:3.4.22.62]
102516958  APPL1; DCC-interacting protein 13-alpha isoform X1 [KO:K08733]
102518832  cadherin-1 isoform X2 [KO:K05689]
102508568  CTNNB1; catenin beta-1 [KO:K02105]
102519547  CTNNA1; catenin alpha-1 [KO:K05691]
102513909  CTNNA2; catenin alpha-2 isoform X3 [KO:K05691]
102520395  CTNNA3; catenin alpha-3 isoform X1 [KO:K05691]
102508916  AXIN1; axin-1 isoform X1 [KO:K02157]
102508329  AXIN2; axin-2 isoform X2 [KO:K04385]
102522612  APC; adenomatous polyposis coli protein isoform X1 [KO:K02085]
102521446  APC2; LOW QUALITY PROTEIN: adenomatous polyposis coli protein 2 [KO:K02085]
102504696  GSK3B; glycogen synthase kinase-3 beta isoform X1 [KO:K03083] [EC:2.7.11.26]
102519063  TCF7; LOW QUALITY PROTEIN: transcription factor 7 [KO:K02620]
102516787  TCF7L1; transcription factor 7-like 1 [KO:K04490]
102510763  TCF7L2; transcription factor 7-like 2 isoform X1 [KO:K04491]
102510619  LEF1; lymphoid enhancer-binding factor 1 isoform X2 [KO:K04492]
102511273  BIRC5; baculoviral IAP repeat-containing protein 5 [KO:K08731]
102511086  MYC; myc proto-oncogene protein [KO:K04377]
102518309  CCND1; G1/S-specific cyclin-D1 [KO:K04503]
102521780  WNT1; proto-oncogene Wnt-1 [KO:K03209]
102505341  WNT2; protein Wnt-2 [KO:K00182]
102517871  WNT2B; protein Wnt-2b isoform X1 [KO:K00182]
102513236  WNT3A; protein Wnt-3a [KO:K00312]
102513805  WNT3; proto-oncogene Wnt-3 isoform X2 [KO:K00312]
102522577  WNT4; protein Wnt-4 isoform X1 [KO:K00408]
102505627  WNT5A; LOW QUALITY PROTEIN: protein Wnt-5a [KO:K00444]
102515730  WNT5B; protein Wnt-5b [KO:K00444]
102511574  WNT6; protein Wnt-6 isoform X1 [KO:K00445]
102506800  WNT7A; protein Wnt-7a isoform X1 [KO:K00572]
102519277  WNT7B; protein Wnt-7b isoform X1 [KO:K00572]
102514705  WNT8A; protein Wnt-8a [KO:K00714]
102507167  WNT8B; protein Wnt-8b [KO:K00714]
102513485  WNT9A; protein Wnt-9a isoform X1 [KO:K01064]
102514532  WNT9B; protein Wnt-9b [KO:K01064]
102514687  WNT10B; protein Wnt-10b [KO:K01357]
102511822  WNT10A; protein Wnt-10a [KO:K01357]
102508550  WNT11; protein Wnt-11 isoform X1 [KO:K01384]
102505757  WNT16; protein Wnt-16 [KO:K01558]
102515569  FZD1; frizzled-1 [KO:K02432]
102513375  FZD2; frizzled-2 isoform X2 [KO:K02235]
102507159  FZD3; frizzled-3 [KO:K02329]
102517229  FZD4; frizzled-4 [KO:K02354]
102511876  FZD5; frizzled-5 [KO:K02375]
116661461  FZD8; frizzled-8 [KO:K02375]
102510205  FZD6; frizzled-6 [KO:K02376]
102522470  FZD9; frizzled-9 [KO:K02842]
102523163  FZD10; frizzled-10 [KO:K02842]
102519822  LRP5; low-density lipoprotein receptor-related protein 5 isoform X1 [KO:K03068]
102519762  LRP6; low-density lipoprotein receptor-related protein 6 isoform X1 [KO:K03068]
102516993  DVL2; segment polarity protein dishevelled homolog DVL-2 isoform X1 [KO:K02353]
102504125  DVL1; segment polarity protein dishevelled homolog DVL-1 isoform X1 [KO:K02353]
102508928  DVL3; segment polarity protein dishevelled homolog DVL-3 isoform X1 [KO:K02353]
116667094  FRAT1; proto-oncogene FRAT1 [KO:K03069]
116667093  FRAT2; GSK-3-binding protein FRAT2 [KO:K03096]
102515763  F2; prothrombin [KO:K01313] [EC:3.4.21.5]
102506388  AGT; angiotensinogen [KO:K09821]
102506154  F2R; proteinase-activated receptor 1 isoform X1 [KO:K03914]
102508405  F2RL3; proteinase-activated receptor 4 [KO:K04236]
102522277  LPAR1; lysophosphatidic acid receptor 1 [KO:K04289]
102504628  LPAR2; lysophosphatidic acid receptor 2 isoform X1 [KO:K04291]
102508154  LPAR3; lysophosphatidic acid receptor 3 isoform X1 [KO:K04294]
102505523  LPAR4; lysophosphatidic acid receptor 4 [KO:K04275]
102524474  LPAR5; lysophosphatidic acid receptor 5 [KO:K08390]
102516623  LPAR6; lysophosphatidic acid receptor 6 [KO:K04273]
102524525  GNA12; guanine nucleotide-binding protein subunit alpha-12 [KO:K04346]
116666290  LOW QUALITY PROTEIN: guanine nucleotide-binding protein subunit alpha-12-like [KO:K04346]
102523556  GNA13; guanine nucleotide-binding protein subunit alpha-13 [KO:K04639]
102524302  ARHGEF12; rho guanine nucleotide exchange factor 12 isoform X1 [KO:K07532]
102507476  ARHGEF11; LOW QUALITY PROTEIN: rho guanine nucleotide exchange factor 11 [KO:K12331]
102504201  ARHGEF1; rho guanine nucleotide exchange factor 1 isoform X1 [KO:K12330]
102520493  PLEKHG5; pleckstrin homology domain-containing family G member 5 isoform X1 [KO:K19464]
102507993  RHOA; transforming protein RhoA [KO:K04513]
102520724  ROCK1; rho-associated protein kinase 1 isoform X1 [KO:K04514] [EC:2.7.11.1]
102512572  ROCK2; rho-associated protein kinase 2 isoform X1 [KO:K17388] [EC:2.7.11.1]
102515651  CXCL12; stromal cell-derived factor 1 isoform X1 [KO:K10031]
102513077  CXCR4; C-X-C chemokine receptor type 4 [KO:K04189]
102518290  GNAI1; guanine nucleotide-binding protein G(i) subunit alpha-1 isoform X1 [KO:K04630]
102504487  GNAI3; guanine nucleotide-binding protein G(i) subunit alpha [KO:K04630]
102522331  GNAI2; guanine nucleotide-binding protein G(i) subunit alpha-2 [KO:K04630]
102521921  PTGER1; prostaglandin E2 receptor EP1 subtype isoform X1 [KO:K04258]
102511634  PTGER2; prostaglandin E2 receptor EP2 subtype isoform X1 [KO:K04259]
102506688  PTGER3; LOW QUALITY PROTEIN: prostaglandin E2 receptor EP3 subtype [KO:K04260]
102512418  PTGER4; prostaglandin E2 receptor EP4 subtype [KO:K04261]
102513869  guanine nucleotide-binding protein G(s) subunit alpha isoform X1 [KO:K04632]
102509921  neuroendocrine secretory protein 55 [KO:K04632]
102517882  ADCY1; LOW QUALITY PROTEIN: adenylate cyclase type 1 [KO:K08041] [EC:4.6.1.1]
102510993  ADCY2; adenylate cyclase type 2 isoform X1 [KO:K08042] [EC:4.6.1.1]
102512950  ADCY3; adenylate cyclase type 3 isoform X1 [KO:K08043] [EC:4.6.1.1]
102524031  ADCY4; adenylate cyclase type 4 isoform X1 [KO:K08044] [EC:4.6.1.1]
102503785  ADCY5; adenylate cyclase type 5 isoform X1 [KO:K08045] [EC:4.6.1.1]
102519611  ADCY6; adenylate cyclase type 6 isoform X1 [KO:K08046] [EC:4.6.1.1]
102524614  ADCY7; adenylate cyclase type 7 isoform X1 [KO:K08047] [EC:4.6.1.1]
102521259  ADCY8; adenylate cyclase type 8 isoform X1 [KO:K08048] [EC:4.6.1.1]
102505261  ADCY9; LOW QUALITY PROTEIN: adenylate cyclase type 9 [KO:K08049] [EC:4.6.1.1]
102508985  PRKACA; cAMP-dependent protein kinase catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]
102506255  PRKACB; cAMP-dependent protein kinase catalytic subunit beta isoform X1 [KO:K04345] [EC:2.7.11.11]
102508170  GNB1; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 [KO:K04536]
102508739  GNB2; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 [KO:K04537]
102509553  GNB3; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3 [KO:K07825]
102522482  GNB4; guanine nucleotide-binding protein subunit beta-4 [KO:K04538]
102519051  GNB5; guanine nucleotide-binding protein subunit beta-5 [KO:K04539]
106730449  GNG2; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 [KO:K07826]
102520601  GNG3; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3 [KO:K04540]
116667292  GNG4; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4 [KO:K04541]
116660433  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4-like [KO:K04541]
102504441  GNG5; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 [KO:K04542]
116659069  GNG7; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7 [KO:K04543]
106728499  GNG8; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-8 isoform X1 [KO:K04544]
116663227  GNG10; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 [KO:K04545]
116664980  GNG11; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11 [KO:K04546]
106729205  GNG14; putative guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-14 isoform X3 [KO:K04347]
106730424  GNG12; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12 [KO:K04347]
102506248  GNG13; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-13 [KO:K04547]
116665109  GNGT1; guanine nucleotide-binding protein G(T) subunit gamma-T1 [KO:K04548]
106730907  GNGT2; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2 isoform X1 [KO:K04549]
102524319  COL4A3; LOW QUALITY PROTEIN: collagen alpha-3(IV) chain [KO:K06237]
102524585  COL4A4; LOW QUALITY PROTEIN: collagen alpha-4(IV) chain [KO:K06237]
102509068  COL4A1; collagen alpha-1(IV) chain isoform X1 [KO:K06237]
102508830  COL4A2; LOW QUALITY PROTEIN: collagen alpha-2(IV) chain [KO:K06237]
102520494  COL4A6; collagen alpha-6(IV) chain isoform X1 [KO:K06237]
102521464  COL4A5; collagen alpha-5(IV) chain isoform X1 [KO:K06237]
102505642  LAMA1; laminin subunit alpha-1 isoform X1 [KO:K05637]
102504667  LAMA2; laminin subunit alpha-2 isoform X1 [KO:K05637]
102503954  LAMA5; laminin subunit alpha-5 isoform X1 [KO:K06240]
102507092  LAMA3; LOW QUALITY PROTEIN: laminin subunit alpha-3 [KO:K06240]
102505297  LAMA4; laminin subunit alpha-4 isoform X3 [KO:K06241]
102521906  LAMB1; LOW QUALITY PROTEIN: laminin subunit beta-1 [KO:K05636]
102510254  LAMB2; laminin subunit beta-2 isoform X2 [KO:K06243]
102503746  LAMB3; LOW QUALITY PROTEIN: laminin subunit beta-3 [KO:K06244]
102521665  LAMB4; LOW QUALITY PROTEIN: laminin subunit beta-4 [KO:K06245]
102509312  LAMC1; laminin subunit gamma-1 [KO:K05635]
102509067  LAMC2; laminin subunit gamma-2 [KO:K06246]
102519796  LAMC3; laminin subunit gamma-3 isoform X1 [KO:K06247]
102518759  FN1; fibronectin isoform X1 [KO:K05717]
102522915  ITGA2; integrin alpha-2 [KO:K06481]
102521427  ITGA2B; integrin alpha-IIb isoform X1 [KO:K06476]
102508309  ITGA3; integrin alpha-3 isoform X1 [KO:K06482]
102518543  ITGA6; integrin alpha-6 isoform X1 [KO:K06485]
102508062  ITGAV; integrin alpha-V isoform X2 [KO:K06487]
102509512  ITGB1; integrin beta-1 isoform X1 [KO:K05719]
102523502  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
102518643  PIK3CD; LOW QUALITY PROTEIN: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [KO:K00922] [EC:2.7.1.153]
102519994  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [KO:K00922] [EC:2.7.1.153]
102513205  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta isoform X1 [KO:K02649]
102505690  LOW QUALITY PROTEIN: phosphatidylinositol 3-kinase regulatory subunit gamma [KO:K02649]
102520923  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X2 [KO:K02649]
102515104  PTEN; phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
116660739  NKX3-1; homeobox protein Nkx-3.1 [KO:K09348]
102503460  AKT2; RAC-beta serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
102515350  AKT3; RAC-gamma serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
102519101  RAC-gamma serine/threonine-protein kinase-like [KO:K04456] [EC:2.7.11.1]
106729149  AKT1; LOW QUALITY PROTEIN: RAC-alpha serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
102503497  CHUK; inhibitor of nuclear factor kappa-B kinase subunit alpha isoform X1 [KO:K04467] [EC:2.7.11.10]
102508142  IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta [KO:K07209] [EC:2.7.11.10]
102519782  IKBKG; NF-kappa-B essential modulator isoform X1 [KO:K07210]
102519409  NFKBIA; NF-kappa-B inhibitor alpha [KO:K04734]
102505905  NFKB1; nuclear factor NF-kappa-B p105 subunit isoform X1 [KO:K02580]
102515933  NFKB2; nuclear factor NF-kappa-B p100 subunit isoform X1 [KO:K04469]
102506204  RELA; transcription factor p65 isoform X1 [KO:K04735]
102509586  PTGS2; prostaglandin G/H synthase 2 [KO:K11987] [EC:1.14.99.1]
102518523  NOS2; nitric oxide synthase, inducible isoform X1 [KO:K13241] [EC:1.14.13.39]
102518434  BCL2; apoptosis regulator Bcl-2 isoform X1 [KO:K02161]
102513991  BIRC2; baculoviral IAP repeat-containing protein 2 [KO:K16060]
102513751  baculoviral IAP repeat-containing protein 3 [KO:K16060]
102507842  XIAP; E3 ubiquitin-protein ligase XIAP isoform X2 [KO:K04725] [EC:2.3.2.27]
102504500  BIRC7; baculoviral IAP repeat-containing protein 7 isoform X1 [KO:K16061]
102504996  BCL2L1; bcl-2-like protein 1 isoform X2 [KO:K04570]
102511048  TRAF1; TNF receptor-associated factor 1 isoform X1 [KO:K03172]
102511649  TRAF2; TNF receptor-associated factor 2 isoform X1 [KO:K03173] [EC:2.3.2.27]
102515034  TRAF3; TNF receptor-associated factor 3 isoform X1 [KO:K03174]
102507612  TRAF4; TNF receptor-associated factor 4 isoform X1 [KO:K09848]
102507430  TRAF5; TNF receptor-associated factor 5 isoform X1 [KO:K09849]
102520181  TRAF6; TNF receptor-associated factor 6 [KO:K03175] [EC:2.3.2.27]
102510836  MTOR; serine/threonine-protein kinase mTOR isoform X1 [KO:K07203] [EC:2.7.11.1]
102518322  RPS6KB2; LOW QUALITY PROTEIN: ribosomal protein S6 kinase beta-2 [KO:K04688] [EC:2.7.11.1]
102511731  RPS6KB1; ribosomal protein S6 kinase beta-1 isoform X1 [KO:K04688] [EC:2.7.11.1]
102523295  BAD; bcl2-associated agonist of cell death isoform X2 [KO:K02158]
102511562  FOXO1; forkhead box protein O1 isoform X1 [KO:K07201]
102522420  MDM2; E3 ubiquitin-protein ligase Mdm2 isoform X1 [KO:K06643] [EC:2.3.2.27]
102524476  TP53; cellular tumor antigen p53 [KO:K04451]
102518884  CDKN1B; cyclin-dependent kinase inhibitor 1B [KO:K06624]
102509404  CDKN1A; cyclin-dependent kinase inhibitor 1 isoform X2 [KO:K06625]
102509438  BCR; breakpoint cluster region protein isoform X1 [KO:K08878] [EC:2.7.11.1]
102519310  ABL1; tyrosine-protein kinase ABL1 isoform X2 [KO:K06619] [EC:2.7.10.2]
102516584  CRKL; crk-like protein [KO:K04438]
102511476  CRK; adapter molecule crk isoform X1 [KO:K04438]
102504124  CBL; E3 ubiquitin-protein ligase CBL [KO:K04707] [EC:2.3.2.27]
102520794  signal transducer and activator of transcription 5A [KO:K11223]
102511001  STAT5B; signal transducer and activator of transcription 5B isoform X1 [KO:K11224]
102520706  PIM1; serine/threonine-protein kinase pim-1 [KO:K04702] [EC:2.7.11.1]
102509083  PIM2; serine/threonine-protein kinase pim-2 [KO:K08806] [EC:2.7.11.1]
102511736  KNG1; kininogen-1 isoform X2 [KO:K03898]
102508685  EDN1; endothelin-1 [KO:K16366]
102503589  BDKRB1; LOW QUALITY PROTEIN: B1 bradykinin receptor [KO:K03915]
102503838  BDKRB2; B2 bradykinin receptor isoform X1 [KO:K03916]
102518725  EDNRA; endothelin-1 receptor [KO:K04197]
102516043  EDNRB; endothelin receptor type B [KO:K04198]
102508547  GNAQ; guanine nucleotide-binding protein G(q) subunit alpha isoform X1 [KO:K04634]
102508599  GNA11; guanine nucleotide-binding protein subunit alpha-11 [KO:K04635]
102509058  PLCB2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 isoform X3 [KO:K05858] [EC:3.1.4.11]
102505338  PLCB3; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 isoform X1 [KO:K05858] [EC:3.1.4.11]
102513996  PLCB1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 isoform X1 [KO:K05858] [EC:3.1.4.11]
102513431  PLCB4; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 isoform X1 [KO:K05858] [EC:3.1.4.11]
102507832  PRKCA; protein kinase C alpha type isoform X1 [KO:K02677] [EC:2.7.11.13]
102511859  PRKCB; protein kinase C beta type isoform X1 [KO:K19662] [EC:2.7.11.13]
102513516  PRKCG; protein kinase C gamma type [KO:K19663] [EC:2.7.11.13]
102514894  IL2; interleukin-2 [KO:K05429]
102515500  IL4; interleukin-4 isoform X2 [KO:K05430]
102522050  IL5; interleukin-5 isoform X2 [KO:K05428]
102515320  IL6; interleukin-6 [KO:K05405]
102504417  IL7; interleukin-7 isoform X1 [KO:K05431]
102507202  IL12A; interleukin-12 subunit alpha isoform X2 [KO:K05406]
102515488  IL12B; interleukin-12 subunit beta [KO:K05425]
102515236  IL13; interleukin-13 isoform X2 [KO:K05435]
102524066  IL15; interleukin-15 [KO:K05433]
102511458  IL23A; interleukin-23 subunit alpha [KO:K05426]
102508972  EPO; erythropoietin [KO:K05437]
102519964  interferon alpha-1-like [KO:K05414]
102513158  LOW QUALITY PROTEIN: interferon alpha-14 [KO:K05414]
102516460  interferon alpha-14-like [KO:K05414]
106730619  LOW QUALITY PROTEIN: interferon alpha-14-like [KO:K05414]
102513056  interferon alpha-3-like [KO:K05414]
102512333  interferon alpha-1-like [KO:K05414]
116663075  interferon alpha-1-like [KO:K05414]
116663078  interferon alpha-1-like [KO:K05414]
102504614  IFNG; interferon gamma [KO:K04687]
102520401  IL2RA; interleukin-2 receptor subunit alpha isoform X1 [KO:K05068]
102524470  IL2RB; LOW QUALITY PROTEIN: interleukin-2 receptor subunit beta [KO:K05069]
102512136  IL3RA; interleukin-3 receptor subunit alpha [KO:K04737]
102504937  IL4R; interleukin-4 receptor subunit alpha isoform X1 [KO:K05071]
102504038  cytokine receptor common subunit beta isoform X1 [KO:K04738]
106731105  CSF2RB; cytokine receptor common subunit beta [KO:K04738]
102509405  IL5RA; interleukin-5 receptor subunit alpha [KO:K05067]
102511771  IL6R; interleukin-6 receptor subunit alpha [KO:K05055]
102511873  IL6ST; interleukin-6 receptor subunit beta [KO:K05060]
102515501  IL7R; interleukin-7 receptor subunit alpha isoform X1 [KO:K05072]
102512953  IL12RB1; interleukin-12 receptor subunit beta-1 [KO:K05063]
102523963  IL12RB2; interleukin-12 receptor subunit beta-2 isoform X1 [KO:K05064]
102509671  IL13RA1; interleukin-13 receptor subunit alpha-1 [KO:K05076]
102520156  IL15RA; interleukin-15 receptor subunit alpha isoform X3 [KO:K05074]
102523704  IL23R; interleukin-23 receptor [KO:K05065]
102509678  EPOR; erythropoietin receptor isoform X3 [KO:K05079]
102523764  IFNAR1; LOW QUALITY PROTEIN: interferon alpha/beta receptor 1 [KO:K05130]
102518206  IFNAR2; interferon alpha/beta receptor 2 [KO:K05131]
102522759  IFNGR1; interferon gamma receptor 1 isoform X1 [KO:K05132]
102523264  IFNGR2; interferon gamma receptor 2 isoform X1 [KO:K05133]
102507317  EML4; echinoderm microtubule-associated protein-like 4 isoform X2 [KO:K15420]
102504436  ALK; LOW QUALITY PROTEIN: ALK tyrosine kinase receptor [KO:K05119] [EC:2.7.10.1]
102511050  RASGRP1; RAS guanyl-releasing protein 1 isoform X1 [KO:K04350]
102515600  RASGRP2; RAS guanyl-releasing protein 2 isoform X1 [KO:K12361]
102506193  RASGRP3; ras guanyl-releasing protein 3 isoform X1 [KO:K12362]
102510291  RASGRP4; RAS guanyl-releasing protein 4 isoform X2 [KO:K12363]
102519873  JAK1; tyrosine-protein kinase JAK1 [KO:K11217] [EC:2.7.10.2]
102520220  JAK2; LOW QUALITY PROTEIN: tyrosine-protein kinase JAK2 [KO:K04447] [EC:2.7.10.2]
102503866  JAK3; tyrosine-protein kinase JAK3 [KO:K11218] [EC:2.7.10.2]
102520228  STAT3; signal transducer and activator of transcription 3 isoform X4 [KO:K04692]
102509999  STAT1; signal transducer and activator of transcription 1-alpha/beta isoform X4 [KO:K11220]
102510903  STAT2; LOW QUALITY PROTEIN: signal transducer and activator of transcription 2 [KO:K11221]
102509760  STAT4; signal transducer and activator of transcription 4 isoform X1 [KO:K11222]
102512918  STAT6; signal transducer and activator of transcription 6 isoform X3 [KO:K11225]
102514843  VEGFA; vascular endothelial growth factor A [KO:K05448]
102520919  PGF; placenta growth factor isoform X5 [KO:K16859]
102514127  VEGFC; vascular endothelial growth factor C [KO:K05449]
102522536  VEGFD; vascular endothelial growth factor D [KO:K05449]
102506694  TGFA; protransforming growth factor alpha [KO:K08774]
102523769  EGF; pro-epidermal growth factor isoform X1 [KO:K04357]
102504272  EGFR; LOW QUALITY PROTEIN: epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]
102519604  ERBB2; receptor tyrosine-protein kinase erbB-2 [KO:K05083] [EC:2.7.10.1]
102520052  PDGFA; platelet-derived growth factor subunit A isoform X1 [KO:K04359]
102509299  PDGFB; platelet-derived growth factor subunit B [KO:K17386]
102512589  PDGFRA; LOW QUALITY PROTEIN: platelet-derived growth factor receptor alpha [KO:K04363] [EC:2.7.10.1]
102512951  PDGFRB; platelet-derived growth factor receptor beta [KO:K05089] [EC:2.7.10.1]
102506236  IGF1; insulin-like growth factor I isoform X1 [KO:K05459]
102515540  IGF2; insulin-like growth factor II isoform X1 [KO:K13769]
102524338  IGF1R; insulin-like growth factor 1 receptor isoform X1 [KO:K05087] [EC:2.7.10.1]
102506677  KITLG; kit ligand isoform X1 [KO:K05461]
102521127  KIT; LOW QUALITY PROTEIN: mast/stem cell growth factor receptor Kit [KO:K05091] [EC:2.7.10.1]
102518463  FLT3LG; fms-related tyrosine kinase 3 ligand isoform X1 [KO:K05454]
102508422  FLT3; receptor-type tyrosine-protein kinase FLT3 isoform X1 [KO:K05092] [EC:2.7.10.1]
102515749  HGF; hepatocyte growth factor isoform X2 [KO:K05460]
102504138  hepatocyte growth factor receptor isoform X3 [KO:K05099] [EC:2.7.10.1]
102513829  FGF1; fibroblast growth factor 1 isoform X1 [KO:K18496]
102523878  FGF9; fibroblast growth factor 9 isoform X5 [KO:K04358]
102523201  FGF22; fibroblast growth factor 22 isoform X1 [KO:K04358]
102506593  FGF6; fibroblast growth factor 6 [KO:K04358]
102522544  FGF17; fibroblast growth factor 17 isoform X1 [KO:K04358]
102506811  FGF8; fibroblast growth factor 8 [KO:K04358]
102520066  FGF5; fibroblast growth factor 5 isoform X1 [KO:K04358]
102513465  FGF10; fibroblast growth factor 10 [KO:K04358]
102506716  FGF16; fibroblast growth factor 16 [KO:K04358]
102524081  FGF18; fibroblast growth factor 18 isoform X1 [KO:K04358]
102519120  FGF7; fibroblast growth factor 7 [KO:K04358]
102504464  FGF20; fibroblast growth factor 20 [KO:K04358]
116666646  FGF4; fibroblast growth factor 4 [KO:K04358]
116666647  FGF3; fibroblast growth factor 3 [KO:K04358]
102514176  FGF21; fibroblast growth factor 21 [KO:K22429]
102510802  FGF23; fibroblast growth factor 23 [KO:K22428]
102515264  FGFR1; fibroblast growth factor receptor 1 isoform X1 [KO:K04362] [EC:2.7.10.1]
102516073  FGFR2; fibroblast growth factor receptor 2 isoform X1 [KO:K05093] [EC:2.7.10.1]
102512878  FGFR3; fibroblast growth factor receptor 3 isoform X1 [KO:K05094] [EC:2.7.10.1]
102510147  FGFR4; fibroblast growth factor receptor 4 isoform X1 [KO:K05095] [EC:2.7.10.1]
102515306  GRB2; growth factor receptor-bound protein 2 [KO:K04364]
102507247  SOS1; son of sevenless homolog 1 isoform X1 [KO:K03099]
102517014  SOS2; son of sevenless homolog 2 [KO:K03099]
102524334  HRAS; GTPase HRas isoform X1 [KO:K02833]
102516372  KRAS; GTPase KRas isoform X1 [KO:K07827]
102509562  NRAS; GTPase NRas [KO:K07828]
102506774  ARAF; serine/threonine-protein kinase A-Raf isoform X1 [KO:K08845] [EC:2.7.11.1]
102524100  BRAF; serine/threonine-protein kinase B-raf [KO:K04365] [EC:2.7.11.1]
102517521  RAF1; RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:2.7.11.1]
102515937  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
102511209  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 isoform X1 [KO:K04369] [EC:2.7.12.2]
102517586  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
102521659  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
102516943  JUN; transcription factor AP-1 [KO:K04448]
102519397  FOS; proto-oncogene c-Fos [KO:K04379]
102520999  ETS1; protein C-ets-1 isoform X5 [KO:K02678]
102517049  MMP1; interstitial collagenase [KO:K01388] [EC:3.4.24.7]
102521167  MMP2; 72 kDa type IV collagenase isoform X1 [KO:K01398] [EC:3.4.24.24]
102509767  MMP9; matrix metalloproteinase-9 [KO:K01403] [EC:3.4.24.35]
102506409  CXCL8; interleukin-8 [KO:K10030]
102522300  CDK4; cyclin-dependent kinase 4 [KO:K02089] [EC:2.7.11.22]
102512204  RPS6KA5; ribosomal protein S6 kinase alpha-5 isoform X1 [KO:K04445] [EC:2.7.11.1]
102514431  RET; proto-oncogene tyrosine-protein kinase receptor Ret isoform X1 [KO:K05126] [EC:2.7.10.1]
102512770  CCDC6; coiled-coil domain-containing protein 6 isoform X1 [KO:K09288]
102514407  NCOA4; nuclear receptor coactivator 4 isoform X2 [KO:K09289]
102518397  NTRK1; high affinity nerve growth factor receptor isoform X1 [KO:K03176] [EC:2.7.10.1]
102518235  TPM3; tropomyosin alpha-3 chain isoform X4 [KO:K09290]
102510769  TPR; LOW QUALITY PROTEIN: nucleoprotein TPR [KO:K09291]
102509771  TFG; protein TFG isoform X1 [KO:K09292]
102520308  RASSF1; ras association domain-containing protein 1 isoform X1 [KO:K09850]
102519008  RASSF5; ras association domain-containing protein 5 isoform X2 [KO:K08015]
102514045  STK4; serine/threonine-protein kinase 4 [KO:K04411]
102506911  DAPK2; death-associated protein kinase 2 isoform X2 [KO:K08803] [EC:2.7.11.1]
102510747  DAPK3; death-associated protein kinase 3 [KO:K08803] [EC:2.7.11.1]
102512779  DAPK1; LOW QUALITY PROTEIN: death-associated protein kinase 1 [KO:K08803] [EC:2.7.11.1]
102524452  PLCG1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X1 [KO:K01116] [EC:3.1.4.11]
102514470  PLCG2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 isoform X1 [KO:K05859] [EC:3.1.4.11]
102507567  ELK1; ETS domain-containing protein Elk-1 [KO:K04375]
102512690  CALM1; calmodulin-1 [KO:K02183]
102516816  CALM3; calmodulin-3 [KO:K02183]
102509134  CALML6; LOW QUALITY PROTEIN: calmodulin-like protein 6 [KO:K02183]
102517946  CALML4; calmodulin-like protein 4 isoform X1 [KO:K02183]
102512134  CALM2; calmodulin-2 [KO:K02183]
102518712  calmodulin [KO:K02183]
102522167  CAMK2G; calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X1 [KO:K04515] [EC:2.7.11.17]
102512557  CAMK2A; calcium/calmodulin-dependent protein kinase type II subunit alpha isoform X1 [KO:K04515] [EC:2.7.11.17]
102521522  CAMK2D; calcium/calmodulin-dependent protein kinase type II subunit delta isoform X1 [KO:K04515] [EC:2.7.11.17]
102506589  CAMK2B; calcium/calmodulin-dependent protein kinase type II subunit beta isoform X1 [KO:K04515] [EC:2.7.11.17]
102503669  RALGDS; LOW QUALITY PROTEIN: ral guanine nucleotide dissociation stimulator [KO:K08732]
102518761  RALA; LOW QUALITY PROTEIN: ras-related protein Ral-A [KO:K07834]
102523710  RALB; ras-related protein Ral-B isoform X1 [KO:K07835]
102506658  RALBP1; ralA-binding protein 1 isoform X1 [KO:K08773]
102514486  CDC42; cell division control protein 42 homolog isoform X1 [KO:K04393]
102516893  RAC1; ras-related C3 botulinum toxin substrate 1 isoform X1 [KO:K04392]
102519112  RAC2; ras-related C3 botulinum toxin substrate 2 isoform X1 [KO:K07860]
102508710  RAC3; ras-related C3 botulinum toxin substrate 3 isoform X1 [KO:K07861]
102520901  PLD2; phospholipase D2 isoform X2 [KO:K01115] [EC:3.1.4.4]
102505040  PLD1; phospholipase D1 isoform X3 [KO:K01115] [EC:3.1.4.4]
102518561  MAPK9; mitogen-activated protein kinase 9 isoform X1 [KO:K04440] [EC:2.7.11.24]
102509448  MAPK10; mitogen-activated protein kinase 10 isoform X1 [KO:K04440] [EC:2.7.11.24]
102503577  MAPK8; mitogen-activated protein kinase 8 isoform X1 [KO:K04440] [EC:2.7.11.24]
102522995  PAX8; paired box protein Pax-8 isoform X1 [KO:K09293]
102516350  PPARG; peroxisome proliferator-activated receptor gamma isoform X1 [KO:K08530]
102518674  RXRA; retinoic acid receptor RXR-alpha isoform X1 [KO:K08524]
102517692  RXRB; retinoic acid receptor RXR-beta isoform X1 [KO:K08525]
102517333  RXRG; retinoic acid receptor RXR-gamma isoform X1 [KO:K08526]
102522439  RARB; retinoic acid receptor beta isoform X2 [KO:K08528]
102519728  ESR1; estrogen receptor isoform X1 [KO:K08550]
102504310  ESR2; estrogen receptor beta isoform X3 [KO:K08551]
102511907  NCOA1; nuclear receptor coactivator 1 isoform X1 [KO:K09101] [EC:2.3.1.48]
102516884  NCOA3; nuclear receptor coactivator 3 isoform X1 [KO:K11256] [EC:2.3.1.48]
102520683  SP1; transcription factor Sp1 [KO:K04684]
102508262  PPARD; peroxisome proliferator-activated receptor delta isoform X1 [KO:K04504]
102515318  JUP; junction plakoglobin [KO:K10056]
102509663  ZBTB16; zinc finger and BTB domain-containing protein 16 isoform X1 [KO:K10055]
102503688  RARA; retinoic acid receptor alpha isoform X1 [KO:K08527]
102513162  CCNA2; cyclin-A2 [KO:K06627]
102517118  CCNA1; cyclin-A1 [KO:K06627]
102504760  PML; protein PML isoform X1 [KO:K10054] [EC:2.3.2.-]
102521748  RUNX1; runt-related transcription factor 1 isoform X1 [KO:K08367]
102516825  RUNX1T1; protein CBFA2T1 isoform X1 [KO:K10053]
102512798  SPI1; transcription factor PU.1 isoform X1 [KO:K09438]
102510087  CEBPA; CCAAT/enhancer-binding protein alpha [KO:K09055]
102511890  CSF2RA; granulocyte-macrophage colony-stimulating factor receptor subunit alpha isoform X1 [KO:K05066]
102505807  CSF3R; granulocyte colony-stimulating factor receptor [KO:K05061]
102513202  CSF1R; macrophage colony-stimulating factor 1 receptor [KO:K05090] [EC:2.7.10.1]
102517211  cyclin-dependent kinase inhibitor 2A isoform X1 [KO:K06621]
102517851  E2F1; transcription factor E2F1 [KO:K17454]
102515523  E2F2; transcription factor E2F2 [KO:K09389]
102513737  E2F3; transcription factor E2F3 isoform X1 [KO:K06620]
102505857  MAX; protein max isoform X1 [KO:K04453]
102516215  ZBTB17; LOW QUALITY PROTEIN: zinc finger and BTB domain-containing protein 17 [KO:K10500]
116663067  CDKN2B; cyclin-dependent kinase 4 inhibitor B [KO:K04685]
102520456  CDK6; cyclin-dependent kinase 6 isoform X1 [KO:K02091] [EC:2.7.11.22]
116661359  CCND2; G1/S-specific cyclin-D2 [KO:K10151]
102524562  CCND3; G1/S-specific cyclin-D3 isoform X1 [KO:K10152]
102504059  CKS1B; cyclin-dependent kinases regulatory subunit 1 [KO:K02219]
102507493  CKS2; cyclin-dependent kinases regulatory subunit 2 [KO:K02219]
102519293  SKP1; S-phase kinase-associated protein 1 [KO:K03094]
102517054  CUL1; cullin-1 [KO:K03347]
102515877  RBX1; E3 ubiquitin-protein ligase RBX1 [KO:K03868] [EC:2.3.2.32]
102523584  SKP2; S-phase kinase-associated protein 2 isoform X1 [KO:K03875]
102504649  CDK2; cyclin-dependent kinase 2 isoform X1 [KO:K02206] [EC:2.7.11.22]
102516466  CCNE1; G1/S-specific cyclin-E1 [KO:K06626]
102512815  CCNE2; G1/S-specific cyclin-E2 isoform X1 [KO:K06626]
102516870  RB1; retinoblastoma-associated protein isoform X1 [KO:K06618]
102516207  GADD45B; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
102508482  GADD45A; LOW QUALITY PROTEIN: growth arrest and DNA damage-inducible protein GADD45 alpha [KO:K04402]
116660720  GADD45G; growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402]
102512073  ferritin light chain isoform X1 [KO:K02159]
102513729  BAK1; bcl-2 homologous antagonist/killer isoform X1 [KO:K14021]
102523860  DDB2; DNA damage-binding protein 2 isoform X4 [KO:K10140]
102507560  POLK; DNA polymerase kappa isoform X1 [KO:K03511] [EC:2.7.7.7]
102510014  TERT; telomerase reverse transcriptase isoform X1 [KO:K11126] [EC:2.7.7.49]
102513508  MITF; microphthalmia-associated transcription factor isoform X1 [KO:K09455]
102509937  TGFB1; transforming growth factor beta-1 proprotein isoform X1 [KO:K13375]
102505811  TGFB2; transforming growth factor beta-2 proprotein isoform X1 [KO:K13376]
102517948  TGFB3; transforming growth factor beta-3 proprotein [KO:K13377]
102522485  TGFBR1; TGF-beta receptor type-1 isoform X1 [KO:K04674] [EC:2.7.11.30]
102509744  TGFBR2; TGF-beta receptor type-2 isoform X1 [KO:K04388] [EC:2.7.11.30]
102508588  SMAD2; mothers against decapentaplegic homolog 2 isoform X1 [KO:K04500]
102523073  SMAD3; mothers against decapentaplegic homolog 3 isoform X1 [KO:K23605]
102507868  SMAD4; mothers against decapentaplegic homolog 4 isoform X1 [KO:K04501]
102519252  MECOM; histone-lysine N-methyltransferase MECOM isoform X2 [KO:K04462] [EC:2.1.1.367]
102508242  CTBP1; C-terminal-binding protein 1 isoform X1 [KO:K04496] [EC:1.1.1.428]
102519579  CTBP2; LOW QUALITY PROTEIN: C-terminal-binding protein 2 [KO:K04496] [EC:1.1.1.428]
102508320  HDAC1; histone deacetylase 1 [KO:K06067] [EC:3.5.1.98]
102504100  HDAC2; histone deacetylase 2 [KO:K06067] [EC:3.5.1.98]
102517643  MLH1; DNA mismatch repair protein Mlh1 isoform X2 [KO:K08734]
102512861  MSH2; DNA mismatch repair protein Msh2 [KO:K08735]
102505126  MSH3; DNA mismatch repair protein Msh3 isoform X1 [KO:K08736]
102513599  MSH6; DNA mismatch repair protein Msh6 [KO:K08737]
102515425  BRCA2; LOW QUALITY PROTEIN: breast cancer type 2 susceptibility protein [KO:K08775]
102523879  RAD51; DNA repair protein RAD51 homolog 1 [KO:K04482]
102503604  FASLG; tumor necrosis factor ligand superfamily member 6 [KO:K04389]
102518538  FAS; tumor necrosis factor receptor superfamily member 6 isoform X1 [KO:K04390]
102519266  FADD; FAS-associated death domain protein [KO:K02373]
102508224  CASP8; caspase-8 [KO:K04398] [EC:3.4.22.61]
102522363  BID; BH3-interacting domain death agonist isoform X1 [KO:K04726]
106729352  PMAIP1; phorbol-12-myristate-13-acetate-induced protein 1 [KO:K10131]
102512800  BBC3; bcl-2-binding component 3 [KO:K10132]
102519481  BCL2L11; bcl-2-like protein 11 isoform X1 [KO:K16341]
102524306  cytochrome c [KO:K08738]
116663281  cytochrome c-like [KO:K08738]
116663681  LOW QUALITY PROTEIN: cytochrome c, testis-specific-like [KO:K08738]
102516966  APAF1; apoptotic protease-activating factor 1 isoform X3 [KO:K02084]
102509752  CASP7; caspase-7 [KO:K04397] [EC:3.4.22.60]
102508840  KEAP1; kelch-like ECH-associated protein 1 [KO:K10456]
102507191  NFE2L2; nuclear factor erythroid 2-related factor 2 isoform X2 [KO:K05638]
102505023  HMOX1; heme oxygenase 1 [KO:K00510] [EC:1.14.14.18]
102514377  NQO1; NAD(P)H dehydrogenase [quinone] 1 isoform X1 [KO:K00355] [EC:1.6.5.2]
102516822  MGST3; microsomal glutathione S-transferase 3 [KO:K00799] [EC:2.5.1.18]
102508758  glutathione S-transferase Mu 1 isoform X1 [KO:K00799] [EC:2.5.1.18]
102506036  glutathione S-transferase Mu 1 [KO:K00799] [EC:2.5.1.18]
102505780  GSTM4; LOW QUALITY PROTEIN: glutathione S-transferase Mu 4 [KO:K00799] [EC:2.5.1.18]
102504562  glutathione S-transferase theta-3-like [KO:K00799] [EC:2.5.1.18]
102504304  glutathione S-transferase theta-1 isoform X1 [KO:K00799] [EC:2.5.1.18]
102514464  glutathione S-transferase A1 isoform X2 [KO:K00799] [EC:2.5.1.18]
102514716  glutathione S-transferase A4 [KO:K00799] [EC:2.5.1.18]
102519717  glutathione S-transferase-like [KO:K00799] [EC:2.5.1.18]
102519947  glutathione S-transferase A4 [KO:K00799] [EC:2.5.1.18]
102523663  glutathione S-transferase omega-2 isoform X1 [KO:K00799] [EC:2.5.1.18]
102523245  glutathione S-transferase omega-1 [KO:K00799] [EC:2.5.1.18]
102512576  MGST1; microsomal glutathione S-transferase 1 [KO:K00799] [EC:2.5.1.18]
102519140  GSTM3; glutathione S-transferase Mu 3 [KO:K00799] [EC:2.5.1.18]
102518805  glutathione S-transferase theta-4 isoform X1 [KO:K00799] [EC:2.5.1.18]
102506605  MGST2; LOW QUALITY PROTEIN: microsomal glutathione S-transferase 2 [KO:K00799] [EC:2.5.1.18]
102522092  glutathione S-transferase P [KO:K23790] [EC:2.5.1.18]
102521850  GSTP1; glutathione S-transferase P isoform X2 [KO:K23790] [EC:2.5.1.18]
102518987  TXNRD1; thioredoxin reductase 1, cytoplasmic [KO:K22182] [EC:1.8.1.9]
102510414  TXNRD3; thioredoxin reductase 3 isoform X1 [KO:K22182] [EC:1.8.1.9]
102522497  TXNRD2; thioredoxin reductase 2, mitochondrial isoform X1 [KO:K22182] [EC:1.8.1.9]
102523003  ELOC; elongin-C [KO:K03872]
102503650  ELOB; elongin-B [KO:K03873]
102519398  elongin-B [KO:K03873]
102503617  CUL2; cullin-2 isoform X1 [KO:K03870]
102505367  EGLN1; egl nine homolog 1 isoform X2 [KO:K09592] [EC:1.14.11.29]
102513612  LOW QUALITY PROTEIN: egl nine homolog 2 [KO:K09592] [EC:1.14.11.29]
102507989  EGLN2; egl nine homolog 2 isoform X1 [KO:K09592] [EC:1.14.11.29]
102516321  EGLN3; egl nine homolog 3 [KO:K09592] [EC:1.14.11.29]
102513098  FH; fumarate hydratase, mitochondrial [KO:K01679] [EC:4.2.1.2]
102514077  HIF1A; hypoxia-inducible factor 1-alpha isoform X1 [KO:K08268]
102517299  EPAS1; endothelial PAS domain-containing protein 1 [KO:K09095]
102511573  ARNT; aryl hydrocarbon receptor nuclear translocator isoform X1 [KO:K09097]
102521434  ARNT2; aryl hydrocarbon receptor nuclear translocator 2 [KO:K15589]
102515619  EP300; histone acetyltransferase p300 [KO:K04498] [EC:2.3.1.48]
102505509  CREBBP; CREB-binding protein [KO:K04498] [EC:2.3.1.48]
102516476  SLC2A1; solute carrier family 2, facilitated glucose transporter member 1 [KO:K07299]
102511823  JAG1; protein jagged-1 [KO:K06052]
102514490  JAG2; protein jagged-2 isoform X1 [KO:K21635]
102510495  DLL4; delta-like protein 4 [KO:K06051]
102511280  DLL3; delta-like protein 3 [KO:K06051]
102513087  DLL1; delta-like protein 1 isoform X1 [KO:K06051]
102515615  NOTCH1; LOW QUALITY PROTEIN: neurogenic locus notch homolog protein 1 [KO:K02599]
102517418  NOTCH2; LOW QUALITY PROTEIN: neurogenic locus notch homolog protein 2 [KO:K20994]
102522765  NOTCH3; neurogenic locus notch homolog protein 3 [KO:K20995]
102507311  NOTCH4; neurogenic locus notch homolog protein 4 isoform X1 [KO:K20996]
102503828  HES1; transcription factor HES-1 isoform X1 [KO:K06054]
116668151  HES5; transcription factor HES-5 [KO:K06055]
102509594  HEYL; hairy/enhancer-of-split related with YRPW motif-like protein isoform X1 [KO:K09091]
102508556  HEY2; hairy/enhancer-of-split related with YRPW motif protein 2 isoform X1 [KO:K09091]
102516693  HEY1; hairy/enhancer-of-split related with YRPW motif protein 1 isoform X2 [KO:K09091]
102504702  FLT4; vascular endothelial growth factor receptor 3 isoform X1 [KO:K05097] [EC:2.7.10.1]
102522058  SHH; sonic hedgehog protein [KO:K11988]
102517641  PTCH1; protein patched homolog 1 isoform X1 [KO:K06225]
102507611  SMO; smoothened homolog isoform X1 [KO:K06226]
102521126  KIF7; kinesin-like protein KIF7 isoform X1 [KO:K18806]
102518116  SUFU; suppressor of fused homolog isoform X1 [KO:K06229]
102516703  GLI1; zinc finger protein GLI1 isoform X1 [KO:K16797]
102510411  GLI2; LOW QUALITY PROTEIN: zinc finger protein GLI2 [KO:K16798]
102509012  GLI3; LOW QUALITY PROTEIN: transcriptional activator GLI3 [KO:K06230]
102514653  BMP2; bone morphogenetic protein 2 [KO:K21283]
102509507  BMP4; bone morphogenetic protein 4 isoform X1 [KO:K04662]
102513186  HHIP; hedgehog-interacting protein [KO:K06231]
102506024  PTCH2; protein patched homolog 2 isoform X2 [KO:K11101]
102504640  AR; androgen receptor [KO:K08557]
102516141  HSP90AA1; heat shock protein HSP 90-alpha isoform X1 [KO:K04079]
102516313  HSP90AB1; heat shock protein HSP 90-beta [KO:K04079]
102517515  HSP90B1; endoplasmin [KO:K09487]
Compound
C00027  Hydrogen peroxide
C00039  DNA
C00076  Calcium cation
C00122  Fumarate
C00149  (S)-Malate
C00165  Diacylglycerol
C00187  Cholesterol
C00280  Androstenedione
C00410  Progesterone
C00416  Phosphatidate
C00533  Nitric oxide
C00535  Testosterone
C00575  3',5'-Cyclic AMP
C00584  Prostaglandin E2
C00681  1-Acyl-sn-glycerol 3-phosphate
C00704  Superoxide
C00735  Cortisol
C00762  Cortisone
C00777  Retinoate
C00951  Estradiol-17beta
C01227  Dehydroepiandrosterone
C01245  D-myo-Inositol 1,4,5-trisphosphate
C01471  Acrolein
C03917  Dihydrotestosterone
C05981  Phosphatidylinositol-3,4,5-trisphosphate
C07653  Flutamide
C15493  9-cis-Retinoic acid
C16038  2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
C16844  Hydroxyl radical
C21641  Hydroperoxyl radical
C21642  4-Hydroxynonenal
Reference
  Authors
Weinberg RA.
  Title
The biology of cancer
  Journal
Garland Science, Taylor & Francis Group, LLC (2007)
Reference
PMID:10647931
  Authors
Hanahan D, Weinberg RA
  Title
The hallmarks of cancer.
  Journal
Cell 100:57-70 (2000)
DOI:10.1016/S0092-8674(00)81683-9
Reference
PMID:15000146
  Authors
Grady WM.
  Title
Genomic instability and colon cancer.
  Journal
Cancer Metastasis Rev 23:11-27 (2004)
DOI:10.1023/A:1025861527711
Reference
PMID:16555243
  Authors
Soreide K, Janssen EA, Soiland H, Korner H, Baak JP.
  Title
Microsatellite instability in colorectal cancer.
  Journal
Br J Surg 93:395-406 (2006)
DOI:10.1002/bjs.5328
Reference
PMID:11078609
  Authors
Anwar S, Hall C, White J, Deakin M, Farrell W, Elder JB.
  Title
Hereditary non-polyposis colorectal cancer: an updated review.
  Journal
Eur J Surg Oncol 26:635-45 (2000)
DOI:10.1053/ejso.2000.0974
Reference
PMID:16699851
  Authors
Takayama T, Miyanishi K, Hayashi T, Sato Y, Niitsu Y.
  Title
Colorectal cancer: genetics of development and metastasis.
  Journal
J Gastroenterol 41:185-92 (2006)
DOI:10.1007/s00535-006-1801-6
Reference
PMID:12621137
  Authors
Lynch HT, de la Chapelle A.
  Title
Hereditary colorectal cancer.
  Journal
N Engl J Med 348:919-32 (2003)
DOI:10.1056/NEJMra012242
Reference
PMID:12951588
  Authors
Rajagopalan H, Nowak MA, Vogelstein B, Lengauer C.
  Title
The significance of unstable chromosomes in colorectal cancer.
  Journal
Nat Rev Cancer 3:695-701 (2003)
DOI:10.1038/nrc1165
Reference
PMID:10505543
  Authors
Behrens J.
  Title
Cadherins and catenins: role in signal transduction and tumor progression.
  Journal
Cancer Metastasis Rev 18:15-30 (1999)
DOI:10.1023/A:1006200102166
Reference
PMID:16042571
  Authors
Behrens J.
  Title
The role of the Wnt signalling pathway in colorectal tumorigenesis.
  Journal
Biochem Soc Trans 33:672-5 (2005)
DOI:10.1042/BST0330672
Reference
PMID:15349822
  Authors
Behrens J, Lustig B.
  Title
The Wnt connection to tumorigenesis.
  Journal
Int J Dev Biol 48:477-87 (2004)
DOI:10.1387/ijdb.041815jb
Reference
PMID:9196022
  Authors
Polakis P.
  Title
The adenomatous polyposis coli (APC) tumor suppressor.
  Journal
Biochim Biophys Acta 1332:F127-47 (1997)
DOI:10.1016/S0304-419X(97)00008-5
Reference
PMID:12737309
  Authors
Janssen KP.
  Title
Murine models of colorectal cancer: studying the role of oncogenic K-ras.
  Journal
Cell Mol Life Sci 60:495-506 (2003)
DOI:10.1007/s000180300041
Reference
PMID:11459867
  Authors
Adjei AA.
  Title
Blocking oncogenic Ras signaling for cancer therapy.
  Journal
J Natl Cancer Inst 93:1062-74 (2001)
DOI:10.1093/jnci/93.14.1062
Reference
PMID:15573119
  Authors
Arakawa H.
  Title
Netrin-1 and its receptors in tumorigenesis.
  Journal
Nat Rev Cancer 4:978-87 (2004)
DOI:10.1038/nrc1504
Reference
PMID:15310786
  Authors
Mehlen P, Fearon ER.
  Title
Role of the dependence receptor DCC in colorectal cancer pathogenesis.
  Journal
J Clin Oncol 22:3420-8 (2004)
DOI:10.1200/JCO.2004.02.019
Reference
PMID:11223406
  Authors
Peltomaki P.
  Title
DNA mismatch repair and cancer.
  Journal
Mutat Res 488:77-85 (2001)
DOI:10.1016/S1383-5742(00)00058-2
Reference
PMID:15711891
  Authors
Li F, Cao Y, Townsend CM Jr, Ko TC.
  Title
TGF-beta signaling in colon cancer cells.
  Journal
World J Surg 29:306-11 (2005)
DOI:10.1007/s00268-004-7813-6
Reference
PMID:11170304
  Authors
Roman C, Saha D, Beauchamp R.
  Title
TGF-beta and colorectal carcinogenesis.
  Journal
Microsc Res Tech 52:450-7 (2001)
DOI:10.1002/1097-0029(20010215)52:4<450::AID-JEMT1030>3.0.CO;2-O
Reference
PMID:16326109
  Authors
Watson AJ.
  Title
An overview of apoptosis and the prevention of colorectal cancer.
  Journal
Crit Rev Oncol Hematol 57:107-21 (2006)
DOI:10.1016/j.critrevonc.2005.06.005
Reference
PMID:15479695
  Authors
Watson AJ.
  Title
Apoptosis and colorectal cancer.
  Journal
Gut 53:1701-9 (2004)
DOI:10.1136/gut.2004.052704
Reference
PMID:11477132
  Authors
Houlston RS.
  Title
What we could do now: molecular pathology of colorectal cancer.
  Journal
Mol Pathol 54:206-14 (2001)
DOI:10.1136/mp.54.4.206
Reference
  Authors
Von Hoff D, Evans D, Hruban R (ed).
  Title
Pancreatic cancer
  Journal
Jones and Bartlett publishers (2005)
Reference
  Authors
Niitsu Y, Yokota J (ed).
  Title
[Oncogenes and Tumor Suppressor Genes for Medical Oncologist] (In Japanese)
  Journal
Nankodo (1999)
Reference
PMID:12459728
  Authors
Bardeesy N, DePinho RA.
  Title
Pancreatic cancer biology and genetics.
  Journal
Nat Rev Cancer 2:897-909 (2002)
DOI:10.1038/nrc949
Reference
PMID:11407945
  Authors
Bardeesy N, Sharpless NE, DePinho RA, Merlino G.
  Title
The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model.
  Journal
Semin Cancer Biol 11:201-18 (2001)
DOI:10.1006/scbi.2000.0371
Reference
PMID:12946833
  Authors
Cowgill SM, Muscarella P.
  Title
The genetics of pancreatic cancer.
  Journal
Am J Surg 186:279-86 (2003)
DOI:10.1016/S0002-9610(03)00226-5
Reference
PMID:16702400
  Authors
Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA.
  Title
Genetics and biology of pancreatic ductal adenocarcinoma.
  Journal
Genes Dev 20:1218-49 (2006)
DOI:10.1101/gad.1415606
Reference
PMID:10740269
  Authors
Shields JM, Pruitt K, McFall A, Shaub A, Der CJ.
  Title
Understanding Ras: 'it ain't over 'til it's over'.
  Journal
Trends Cell Biol 10:147-54 (2000)
DOI:10.1016/S0962-8924(00)01740-2
Reference
PMID:12648469
  Authors
Holbro T, Civenni G, Hynes NE.
  Title
The ErbB receptors and their role in cancer progression.
  Journal
Exp Cell Res 284:99-110 (2003)
DOI:10.1016/S0014-4827(02)00099-X
Reference
PMID:14967450
  Authors
Marmor MD, Skaria KB, Yarden Y.
  Title
Signal transduction and oncogenesis by ErbB/HER receptors.
  Journal
Int J Radiat Oncol Biol Phys 58:903-13 (2004)
DOI:10.1016/j.ijrobp.2003.06.002
Reference
PMID:14586404
  Authors
DeArmond D, Brattain MG, Jessup JM, Kreisberg J, Malik S, Zhao S, Freeman JW.
  Title
Autocrine-mediated ErbB-2 kinase activation of STAT3 is required for growth factor independence of pancreatic cancer cell lines.
  Journal
Oncogene 22:7781-95 (2003)
DOI:10.1038/sj.onc.1206966
Reference
PMID:12545153
  Authors
Wei D, Le X, Zheng L, Wang L, Frey JA, Gao AC, Peng Z, Huang S, Xiong HQ, Abbruzzese JL, Xie K.
  Title
Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis.
  Journal
Oncogene 22:319-29 (2003)
DOI:10.1038/sj.onc.1206122
Reference
PMID:14580692
  Authors
Toyonaga T, Nakano K, Nagano M, Zhao G, Yamaguchi K, Kuroki S, Eguchi T, Chijiiwa K, Tsuneyoshi M, Tanaka M.
  Title
Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer.
  Journal
Cancer Lett 201:107-16 (2003)
DOI:10.1016/S0304-3835(03)00482-8
Reference
PMID:12079267
  Authors
Schmid RM.
  Title
Genetic basis of pancreatic cancer.
  Journal
Best Pract Res Clin Gastroenterol 16:421-33 (2002)
DOI:10.1053/bega.2002.0316
Reference
PMID:15774796
  Authors
Elliott RL, Blobe GC.
  Title
Role of transforming growth factor Beta in human cancer.
  Journal
J Clin Oncol 23:2078-93 (2005)
DOI:10.1200/JCO.2005.02.047
Reference
PMID:15823750
  Authors
Rudkin TM, Foulkes WD.
  Title
BRCA2: breaks, mistakes and failed separations.
  Journal
Trends Mol Med 11:145-8 (2005)
DOI:10.1016/j.molmed.2005.02.003
Reference
PMID:11707511
  Authors
Venkitaraman AR.
  Title
Functions of BRCA1 and BRCA2 in the biological response to DNA damage.
  Journal
J Cell Sci 114:3591-8 (2001)
Reference
PMID:15639402
  Authors
Soni D, King JA, Kaye AH, Hovens CM.
  Title
Genetics of glioblastoma multiforme: mitogenic signaling and cell cycle pathways converge.
  Journal
J Clin Neurosci 12:1-5 (2005)
DOI:10.1016/j.jocn.2004.04.001
Reference
PMID:12154354
  Authors
Zhu Y, Parada LF.
  Title
The molecular and genetic basis of neurological tumours.
  Journal
Nat Rev Cancer 2:616-26 (2002)
DOI:10.1038/nrc866
Reference
PMID:11253051
  Authors
Holland EC.
  Title
Gliomagenesis: genetic alterations and mouse models.
  Journal
Nat Rev Genet 2:120-9 (2001)
DOI:10.1038/35052535
Reference
PMID:16700615
  Authors
Bansal K, Liang ML, Rutka JT.
  Title
Molecular biology of human gliomas.
  Journal
Technol Cancer Res Treat 5:185-94 (2006)
DOI:10.1177/153303460600500302
Reference
  Authors
Tabuchi K (ed).
  Title
[Gliomas: Research and therapy] (In Japanese)
  Journal
Springer-Verlag Tokyo (2006)
Reference
PMID:12762887
  Authors
Kapoor GS, O'Rourke DM.
  Title
Mitogenic signaling cascades in glial tumors.
  Journal
Neurosurgery 52:1425-34; discussion 1434-5 (2003)
DOI:10.1227/01.NEU.0000065135.28143.39
Reference
PMID:16095998
  Authors
Hulleman E, Helin K.
  Title
Molecular mechanisms in gliomagenesis.
  Journal
Adv Cancer Res 94:1-27 (2005)
DOI:10.1016/S0065-230X(05)94001-3
Reference
PMID:11057895
  Authors
Schlessinger J.
  Title
Cell signaling by receptor tyrosine kinases.
  Journal
Cell 103:211-25 (2000)
DOI:10.1016/S0092-8674(00)00114-8
Reference
PMID:9643506
  Authors
Ng HK, Lam PY.
  Title
The molecular genetics of central nervous system tumors.
  Journal
Pathology 30:196-202 (1998)
DOI:10.1080/00313029800169236
Reference
PMID:12084351
  Authors
Knobbe CB, Merlo A, Reifenberger G.
  Title
Pten signaling in gliomas.
  Journal
Neuro-oncol 4:196-211 (2002)
DOI:10.1093/neuonc/4.3.196
Reference
PMID:16557281
  Authors
Kondo T, Ezzat S, Asa SL.
  Title
Pathogenetic mechanisms in thyroid follicular-cell neoplasia.
  Journal
Nat Rev Cancer 6:292-306 (2006)
DOI:10.1038/nrc1836
Reference
PMID:16551846
  Authors
Chiloeches A, Marais R.
  Title
Is BRAF the Achilles' Heel of thyroid cancer?
  Journal
Clin Cancer Res 12:1661-4 (2006)
DOI:10.1158/1078-0432.CCR-06-0051
Reference
PMID:16946003
  Authors
Reddi HV, McIver B, Grebe SK, Eberhardt NL
  Title
The paired box-8/peroxisome proliferator-activated receptor-gamma oncogene in thyroid tumorigenesis.
  Journal
Endocrinology 148:932-5 (2007)
DOI:10.1210/en.2006-0926
Reference
PMID:17062879
  Authors
Santoro M, Melillo RM, Fusco A.
  Title
RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture.
  Journal
Eur J Endocrinol 155:645-653 (2006)
DOI:10.1530/eje.1.02289
Reference
PMID:16242838
  Authors
Pierotti MA, Greco A.
  Title
Oncogenic rearrangements of the NTRK1/NGF receptor.
  Journal
Cancer Lett 232:90-8 (2006)
DOI:10.1016/j.canlet.2005.07.043
Reference
PMID:16189702
  Authors
Sobrinho-Simoes M, Preto A, Rocha AS, Castro P, Maximo V, Fonseca E, Soares P.
  Title
Molecular pathology of well-differentiated thyroid carcinomas.
  Journal
Virchows Arch 447:787-93 (2005)
DOI:10.1007/s00428-005-0065-5
Reference
PMID:11165748
  Authors
Gimm O.
  Title
Thyroid cancer.
  Journal
Cancer Lett 163:143-56 (2001)
DOI:10.1016/S0304-3835(00)00697-2
Reference
PMID:12094241
  Authors
Williams D.
  Title
Cancer after nuclear fallout: lessons from the Chernobyl accident.
  Journal
Nat Rev Cancer 2:543-9 (2002)
DOI:10.1038/nrc845
Reference
PMID:16236521
  Authors
Steffen B, Muller-Tidow C, Schwable J, Berdel WE, Serve H.
  Title
The molecular pathogenesis of acute myeloid leukemia.
  Journal
Crit Rev Oncol Hematol 56:195-221 (2005)
DOI:10.1016/j.critrevonc.2004.10.012
Reference
PMID:12563308
  Authors
Tenen DG.
  Title
Disruption of differentiation in human cancer: AML shows the way.
  Journal
Nat Rev Cancer 3:89-101 (2003)
DOI:10.1038/nrc989
Reference
PMID:16146838
  Authors
Choudhary C, Muller-Tidow C, Berdel WE, Serve H.
  Title
Signal transduction of oncogenic Flt3.
  Journal
Int J Hematol 82:93-9 (2005)
DOI:10.1532/IJH97.05090
Reference
PMID:12951584
  Authors
Stirewalt DL, Radich JP.
  Title
The role of FLT3 in haematopoietic malignancies.
  Journal
Nat Rev Cancer 3:650-65 (2003)
DOI:10.1038/nrc1169
Reference
PMID:16642045
  Authors
Martelli AM, Nyakern M, Tabellini G, Bortul R, Tazzari PL, Evangelisti C, Cocco L.
  Title
Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia.
  Journal
Leukemia 20:911-28 (2006)
DOI:10.1038/sj.leu.2404245
Reference
PMID:15625120
  Authors
Lennartsson J, Jelacic T, Linnekin D, Shivakrupa R.
  Title
Normal and oncogenic forms of the receptor tyrosine kinase kit.
  Journal
Stem Cells 23:16-43 (2005)
DOI:10.1634/stemcells.2004-0117
Reference
PMID:11721960
  Authors
Lorsbach RB, Downing JR.
  Title
The role of the AML1 transcription factor in leukemogenesis.
  Journal
Int J Hematol 74:258-65 (2001)
DOI:10.1007/BF02982058
Reference
PMID:12468433
  Authors
Mizuki M, Schwable J, Steur C, Choudhary C, Agrawal S, Sargin B, Steffen B, Matsumura I, Kanakura Y, Bohmer FD, Muller-Tidow C, Berdel WE, Serve H.
  Title
Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations.
  Journal
Blood 101:3164-73 (2003)
DOI:10.1182/blood-2002-06-1677
Reference
PMID:17554387
  Authors
Mikesch JH, Steffen B, Berdel WE, Serve H, Muller-Tidow C.
  Title
The emerging role of Wnt signaling in the pathogenesis of acute myeloid leukemia.
  Journal
Leukemia 21:1638-47 (2007)
DOI:10.1038/sj.leu.2404732
Reference
PMID:16352814
  Authors
Mueller BU, Pabst T, Fos J, Petkovic V, Fey MF, Asou N, Buergi U, Tenen DG.
  Title
ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression.
  Journal
Blood 107:3330-8 (2006)
DOI:10.1182/blood-2005-07-3068
Reference
PMID:15719031
  Authors
Ren R.
  Title
Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia.
  Journal
Nat Rev Cancer 5:172-83 (2005)
DOI:10.1038/nrc1567
Reference
PMID:11071626
  Authors
Deininger MW, Goldman JM, Melo JV.
  Title
The molecular biology of chronic myeloid leukemia.
  Journal
Blood 96:3343-56 (2000)
Reference
PMID:14982876
  Authors
Calabretta B, Perrotti D.
  Title
The biology of CML blast crisis.
  Journal
Blood 103:4010-22 (2004)
DOI:10.1182/blood-2003-12-4111
Reference
PMID:10403855
  Authors
Faderl S, Talpaz M, Estrov Z, O'Brien S, Kurzrock R, Kantarjian HM.
  Title
The biology of chronic myeloid leukemia.
  Journal
N Engl J Med 341:164-72 (1999)
DOI:10.1056/NEJM199907153410306
Reference
PMID:15156182
  Authors
Mitani K.
  Title
Molecular mechanisms of leukemogenesis by AML1/EVI-1.
  Journal
Oncogene 23:4263-9 (2004)
DOI:10.1038/sj.onc.1207777
Reference
PMID:16484590
  Authors
Dong M, Blobe GC.
  Title
Role of transforming growth factor-beta in hematologic malignancies.
  Journal
Blood 107:4589-96 (2006)
DOI:10.1182/blood-2005-10-4169
Reference
PMID:9834202
  Authors
Kurokawa M, Mitani K, Imai Y, Ogawa S, Yazaki Y, Hirai H.
  Title
The t(3;21) fusion product, AML1/Evi-1, interacts with Smad3 and blocks transforming growth factor-beta-mediated growth inhibition of myeloid cells.
  Journal
Blood 92:4003-12 (1998)
Reference
PMID:12801837
  Authors
Brusa G, Benvenuti M, Mazzacurati L, Mancini M, Pattacini L, Martinelli G, Barbieri E, Greenberger JS, Baccarani M, Santucci MA.
  Title
p53 loss of function enhances genomic instability and accelerates clonal evolution of murine myeloid progenitors expressing the p(210)BCR-ABL tyrosine kinase.
  Journal
Haematologica 88:622-30 (2003)
Reference
PMID:11160144
  Authors
Baldwin AS.
  Title
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.
  Journal
J Clin Invest 107:241-6 (2001)
DOI:10.1172/JCI11991
Reference
PMID:12244301
  Authors
Shin I, Yakes FM, Rojo F, Shin NY, Bakin AV, Baselga J, Arteaga CL.
  Title
PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization.
  Journal
Nat Med 8:1145-52 (2002)
DOI:10.1038/nm759
Reference
PMID:15948971
  Authors
Tilli CM, Van Steensel MA, Krekels GA, Neumann HA, Ramaekers FC.
  Title
Molecular aetiology and pathogenesis of basal cell carcinoma.
  Journal
Br J Dermatol 152:1108-24 (2005)
DOI:10.1111/j.1365-2133.2005.06587.x
Reference
PMID:12588368
  Authors
Saldanha G, Fletcher A, Slater DN.
  Title
Basal cell carcinoma: a dermatopathological and molecular biological update.
  Journal
Br J Dermatol 148:195-202 (2003)
DOI:10.1046/j.1365-2133.2003.05151.x
Reference
PMID:15978322
  Authors
Daya-Grosjean L, Couve-Privat S.
  Title
Sonic hedgehog signaling in basal cell carcinomas.
  Journal
Cancer Lett 225:181-92 (2005)
DOI:10.1016/j.canlet.2004.10.003
Reference
PMID:15468170
  Authors
Tsai KY, Tsao H.
  Title
The genetics of skin cancer.
  Journal
Am J Med Genet C Semin Med Genet 131C:82-92 (2004)
DOI:10.1002/ajmg.c.30037
Reference
PMID:16881963
  Authors
Athar M, Tang X, Lee JL, Kopelovich L, Kim AL.
  Title
Hedgehog signalling in skin development and cancer.
  Journal
Exp Dermatol 15:667-77 (2006)
DOI:10.1111/j.1600-0625.2006.00473.x
Reference
PMID:16306523
  Authors
Rubin AI, Chen EH, Ratner D.
  Title
Basal-cell carcinoma.
  Journal
N Engl J Med 353:2262-9 (2005)
DOI:10.1056/NEJMra044151
Reference
PMID:11276000
  Authors
Saldanha G.
  Title
The Hedgehog signalling pathway and cancer.
  Journal
J Pathol 193:427-32 (2001)
DOI:10.1002/1096-9896(2000)9999:9999<::AID-PATH815>3.0.CO;2-N
Reference
PMID:15270885
  Authors
Saldanha G, Ghura V, Potter L, Fletcher A.
  Title
Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferation.
  Journal
Br J Dermatol 151:157-64 (2004)
DOI:10.1111/j.1365-2133.2004.06048.x
Reference
PMID:14737121
  Authors
Pasca di Magliano M, Hebrok M.
  Title
Hedgehog signalling in cancer formation and maintenance.
  Journal
Nat Rev Cancer 3:903-11 (2003)
DOI:10.1038/nrc1229
Reference
PMID:15656799
  Authors
Reifenberger J, Wolter M, Knobbe CB, Kohler B, Schonicke A, Scharwachter C, Kumar K, Blaschke B, Ruzicka T, Reifenberger G.
  Title
Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas.
  Journal
Br J Dermatol 152:43-51 (2005)
DOI:10.1111/j.1365-2133.2005.06353.x
Reference
PMID:14556242
  Authors
Cohen MM Jr.
  Title
The hedgehog signaling network.
  Journal
Am J Med Genet A 123:5-28 (2003)
DOI:10.1002/ajmg.a.20495
Reference
PMID:11736900
  Authors
Yamazaki F, Aragane Y, Kawada A, Tezuka T.
  Title
Immunohistochemical detection for nuclear beta-catenin in sporadic basal cell carcinoma.
  Journal
Br J Dermatol 145:771-7 (2001)
DOI:10.1046/j.1365-2133.2001.04468.x
Reference
PMID:16054233
  Authors
Erb P, Ji J, Wernli M, Kump E, Glaser A, Buchner SA.
  Title
Role of apoptosis in basal cell and squamous cell carcinoma formation.
  Journal
Immunol Lett 100:68-72 (2005)
DOI:10.1016/j.imlet.2005.06.008
Reference
PMID:11130178
  Authors
Toftgard R.
  Title
Hedgehog signalling in cancer.
  Journal
Cell Mol Life Sci 57:1720-31 (2000)
DOI:10.1007/PL00000654
Reference
PMID:16822996
  Authors
Miller AJ, Mihm MC Jr.
  Title
Melanoma.
  Journal
N Engl J Med 355:51-65 (2006)
DOI:10.1056/NEJMra052166
Reference
PMID:12894244
  Authors
Chin L.
  Title
The genetics of malignant melanoma: lessons from mouse and man.
  Journal
Nat Rev Cancer 3:559-70 (2003)
DOI:10.1038/nrc1145
Reference
PMID:16750612
  Authors
Takata M, Saida T.
  Title
Genetic alterations in melanocytic tumors.
  Journal
J Dermatol Sci 43:1-10 (2006)
DOI:10.1016/j.jdermsci.2006.05.002
Reference
PMID:15841168
  Authors
Chudnovsky Y, Khavari PA, Adams AE.
  Title
Melanoma genetics and the development of rational therapeutics.
  Journal
J Clin Invest 115:813-24 (2005)
DOI:10.1172/JCI24808
Reference
PMID:16001050
  Authors
Merlino G.
  Title
Cancer biology: the weakest link?
  Journal
Nature 436:33-5 (2005)
DOI:10.1038/436033a
Reference
PMID:16001072
  Authors
Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S, Beroukhim R, Milner DA, Granter SR, Du J, Lee C, Wagner SN, Li C, Golub TR, Rimm DL, Meyerson ML, Fisher DE, Sellers WR.
  Title
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.
  Journal
Nature 436:117-22 (2005)
DOI:10.1038/nature03664
Reference
PMID:16899407
  Authors
Levy C, Khaled M, Fisher DE.
  Title
MITF: master regulator of melanocyte development and melanoma oncogene.
  Journal
Trends Mol Med 12:406-14 (2006)
DOI:10.1016/j.molmed.2006.07.008
Reference
PMID:15009714
  Authors
Tsao H, Goel V, Wu H, Yang G, Haluska FG.
  Title
Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma.
  Journal
J Invest Dermatol 122:337-41 (2004)
DOI:10.1046/j.0022-202X.2004.22243.x
Reference
PMID:11224709
  Authors
Gruss C, Herlyn M.
  Title
Role of cadherins and matrixins in melanoma.
  Journal
Curr Opin Oncol 13:117-23 (2001)
DOI:10.1097/00001622-200103000-00006
Reference
PMID:15721476
  Authors
Thompson JF, Scolyer RA, Kefford RF.
  Title
Cutaneous melanoma.
  Journal
Lancet 365:687-701 (2005)
DOI:10.1016/S0140-6736(05)17951-3
Reference
PMID:14695152
  Authors
Omholt K, Platz A, Kanter L, Ringborg U, Hansson J.
  Title
NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression.
  Journal
Clin Cancer Res 9:6483-8 (2003)
Reference
PMID:15557758
  Authors
Hussein MR.
  Title
The TP53 tumor suppressor gene and melanoma tumorigenesis: is there a relationship?
  Journal
Tumour Biol 25:200-7 (2004)
DOI:10.1159/000081103
Reference
PMID:10843728
  Authors
Lazar-Molnar E, Hegyesi H, Toth S, Falus A.
  Title
Autocrine and paracrine regulation by cytokines and growth factors in melanoma.
  Journal
Cytokine 12:547-54 (2000)
DOI:10.1006/cyto.1999.0614
Reference
PMID:16339096
  Authors
Cohen HT, McGovern FJ.
  Title
Renal-cell carcinoma.
  Journal
N Engl J Med 353:2477-90 (2005)
DOI:10.1056/NEJMra043172
Reference
PMID:15122209
  Authors
Pavlovich CP, Schmidt LS.
  Title
Searching for the hereditary causes of renal-cell carcinoma.
  Journal
Nat Rev Cancer 4:381-93 (2004)
DOI:10.1038/nrc1364
Reference
PMID:14634372
  Authors
Linehan WM, Walther MM, Zbar B.
  Title
The genetic basis of cancer of the kidney.
  Journal
J Urol 170:2163-72 (2003)
DOI:10.1097/01.ju.0000096060.92397.ed
Reference
PMID:14685170
  Authors
Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF.
  Title
Met, metastasis, motility and more.
  Journal
Nat Rev Mol Cell Biol 4:915-25 (2003)
DOI:10.1038/nrm1261
Reference
PMID:15611513
  Authors
Kim WY, Kaelin WG.
  Title
Role of VHL gene mutation in human cancer.
  Journal
J Clin Oncol 22:4991-5004 (2004)
DOI:10.1200/JCO.2004.05.061
Reference
PMID:17211469
  Authors
Sudarshan S, Linehan WM, Neckers L.
  Title
HIF and fumarate hydratase in renal cancer.
  Journal
Br J Cancer 96:403-7 (2007)
DOI:10.1038/sj.bjc.6603547
Reference
PMID:17287871
  Authors
Sudarshan S, Pinto PA, Neckers L, Linehan WM.
  Title
Mechanisms of disease: hereditary leiomyomatosis and renal cell cancer--a distinct form of hereditary kidney cancer.
  Journal
Nat Clin Pract Urol 4:104-10 (2007)
DOI:10.1038/ncpuro0711
Reference
PMID:12351585
  Authors
Bodmer D, van den Hurk W, van Groningen JJ, Eleveld MJ, Martens GJ, Weterman MA, van Kessel AG.
  Title
Understanding familial and non-familial renal cell cancer.
  Journal
Hum Mol Genet 11:2489-98 (2002)
DOI:10.1093/hmg/11.20.2489
Reference
PMID:17158541
  Authors
Mitra AP, Datar RH, Cote RJ.
  Title
Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification.
  Journal
J Clin Oncol 24:5552-64 (2006)
DOI:10.1200/JCO.2006.08.2073
Reference
PMID:16474624
  Authors
Wolff EM, Liang G, Jones PA.
  Title
Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer.
  Journal
Nat Clin Pract Urol 2:502-10 (2005)
DOI:10.1038/ncpuro0318
Reference
PMID:16110317
  Authors
Wu XR.
  Title
Urothelial tumorigenesis: a tale of divergent pathways.
  Journal
Nat Rev Cancer 5:713-25 (2005)
DOI:10.1038/nrc1697
Reference
PMID:11103787
  Authors
Brown NS, Jones A, Fujiyama C, Harris AL, Bicknell R.
  Title
Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors.
  Journal
Cancer Res 60:6298-302 (2000)
Reference
PMID:12850530
  Authors
Bellmunt J, Hussain M, Dinney CP.
  Title
Novel approaches with targeted therapies in bladder cancer. Therapy of bladder cancer by blockade of the epidermal growth factor receptor family.
  Journal
Crit Rev Oncol Hematol 46 Suppl:S85-104 (2003)
DOI:10.1016/S1040-8428(03)00067-2
Reference
PMID:17149381
  Authors
Sugano K, Kakizoe T.
  Title
Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging.
  Journal
Nat Clin Pract Urol 3:642-52 (2006)
DOI:10.1038/ncpuro0649
Reference
PMID:15746962
  Authors
Dunn KL, Espino PS, Drobic B, He S, Davie JR.
  Title
The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling.
  Journal
Biochem Cell Biol 83:1-14 (2005)
DOI:10.1139/o04-121
Reference
PMID:15551095
  Authors
Williams SG, Stein JP.
  Title
Molecular pathways in bladder cancer.
  Journal
Urol Res 32:373-85 (2004)
DOI:10.1007/s00240-003-0345-y
Reference
PMID:12878745
  Authors
Nelson WG, De Marzo AM, Isaacs WB.
  Title
Prostate cancer.
  Journal
N Engl J Med 349:366-81 (2003)
DOI:10.1056/NEJMra021562
Reference
PMID:15724144
  Authors
Li L, Ittmann MM, Ayala G, Tsai MJ, Amato RJ, Wheeler TM, Miles BJ, Kadmon D, Thompson TC.
  Title
The emerging role of the PI3-K-Akt pathway in prostate cancer progression.
  Journal
Prostate Cancer Prostatic Dis 8:108-18 (2005)
DOI:10.1038/sj.pcan.4500776
Reference
PMID:16551847
  Authors
Pienta KJ, Bradley D.
  Title
Mechanisms underlying the development of androgen-independent prostate cancer.
  Journal
Clin Cancer Res 12:1665-71 (2006)
DOI:10.1158/1078-0432.CCR-06-0067
Reference
PMID:11900250
  Authors
Feldman BJ, Feldman D.
  Title
The development of androgen-independent prostate cancer.
  Journal
Nat Rev Cancer 1:34-45 (2001)
DOI:10.1038/35094009
Reference
PMID:15082523
  Authors
Heinlein CA, Chang C.
  Title
Androgen receptor in prostate cancer.
  Journal
Endocr Rev 25:276-308 (2004)
DOI:10.1210/er.2002-0032
Reference
PMID:9422516
  Authors
Koivisto P, Kolmer M, Visakorpi T, Kallioniemi OP.
  Title
Androgen receptor gene and hormonal therapy failure of prostate cancer.
  Journal
Am J Pathol 152:1-9 (1998)
Reference
PMID:10835690
  Authors
Zhao XY, Malloy PJ, Krishnan AV, Swami S, Navone NM, Peehl DM, Feldman D.
  Title
Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor.
  Journal
Nat Med 6:703-6 (2000)
DOI:10.1038/76287
Reference
PMID:10453277
  Authors
Macri E, Loda M.
  Title
Role of p27 in prostate carcinogenesis.
  Journal
Cancer Metastasis Rev 17:337-44 (1998)
DOI:10.1023/A:1006133620914
Reference
PMID:11750244
  Authors
Steers WD.
  Title
5alpha-reductase activity in the prostate.
  Journal
Urology 58:17-24; discussion 24 (2001)
DOI:10.1016/S0090-4295(01)01299-7
Reference
PMID:8069858
  Authors
Lin D, Meyer DJ, Ketterer B, Lang NP, Kadlubar FF.
  Title
Effects of human and rat glutathione S-transferases on the covalent DNA binding of the N-acetoxy derivatives of heterocyclic amine carcinogens in vitro: a possible mechanism of organ specificity in their carcinogenesis.
  Journal
Cancer Res 54:4920-6 (1994)
Reference
PMID:11527574
  Authors
Grimes CA, Jope RS.
  Title
The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling.
  Journal
Prog Neurobiol 65:391-426 (2001)
DOI:10.1016/S0301-0082(01)00011-9
Reference
PMID:15947972
  Authors
Ryan AJ, Susil B, Jobling TW, Oehler MK.
  Title
Endometrial cancer.
  Journal
Cell Tissue Res 322:53-61 (2005)
DOI:10.1007/s00441-005-1109-5
Reference
PMID:14747944
  Authors
Lax SF.
  Title
Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.
  Journal
Virchows Arch 444:213-23 (2004)
DOI:10.1007/s00428-003-0947-3
Reference
PMID:16508724
  Authors
Shiozawa T, Konishi I.
  Title
Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.
  Journal
Int J Clin Oncol 11:13-21 (2006)
DOI:10.1007/s10147-005-0546-1
Reference
PMID:17028294
  Authors
Hecht JL, Mutter GL.
  Title
Molecular and pathologic aspects of endometrial carcinogenesis.
  Journal
J Clin Oncol 24:4783-91 (2006)
DOI:10.1200/JCO.2006.06.7173
Reference
PMID:11431710
  Authors
Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P, Prat J.
  Title
Molecular pathology of endometrial hyperplasia and carcinoma.
  Journal
Hum Pathol 32:569-77 (2001)
DOI:10.1053/hupa.2001.25929
Reference
PMID:15284264
  Authors
Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH.
  Title
Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.
  Journal
J Clin Oncol 22:3126-32 (2004)
DOI:10.1200/JCO.2004.11.154
Reference
PMID:7585656
  Authors
Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF.
  Title
Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.
  Journal
Cancer Res 55:5693-8 (1995)
Reference
PMID:16248975
  Authors
Kim D, Chung J.
  Title
Akt: versatile mediator of cell survival and beyond.
  Journal
J Biochem Mol Biol 35:106-15 (2002)
DOI:10.5483/bmbrep.2002.35.1.106
Reference
PMID:12711111
  Authors
Sanchez-Cespedes M.
  Title
Dissecting the genetic alterations involved in lung carcinogenesis.
  Journal
Lung Cancer 40:111-21 (2003)
DOI:10.1016/S0169-5002(03)00033-3
Reference
PMID:11720739
  Authors
Kaye FJ.
  Title
Molecular biology of lung cancer.
  Journal
Lung Cancer 34 Suppl 2:S35-41 (2001)
DOI:10.1016/S0169-5002(01)00342-7
Reference
PMID:12616528
  Authors
Shivapurkar N, Reddy J, Chaudhary PM, Gazdar AF.
  Title
Apoptosis and lung cancer: a review.
  Journal
J Cell Biochem 88:885-98 (2003)
DOI:10.1002/jcb.10440
Reference
PMID:11807782
  Authors
Sartorius UA, Krammer PH.
  Title
Upregulation of Bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines.
  Journal
Int J Cancer 97:584-92 (2002)
DOI:10.1002/ijc.10096
Reference
PMID:16064138
  Authors
Adhikary S, Eilers M.
  Title
Transcriptional regulation and transformation by Myc proteins.
  Journal
Nat Rev Mol Cell Biol 6:635-45 (2005)
DOI:10.1038/nrm1703
Reference
PMID:11463388
  Authors
Spruck C, Strohmaier H, Watson M, Smith AP, Ryan A, Krek TW, Reed SI.
  Title
A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1.
  Journal
Mol Cell 7:639-50 (2001)
DOI:10.1016/S1097-2765(01)00210-6
Reference
PMID:15109562
  Authors
Buttery RC, Rintoul RC, Sethi T.
  Title
Small cell lung cancer: the importance of the extracellular matrix.
  Journal
Int J Biochem Cell Biol 36:1154-60 (2004)
DOI:10.1016/S1357-2725(03)00261-9
Reference
PMID:11559746
  Authors
Yamada KM, Araki M.
  Title
Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis.
  Journal
J Cell Sci 114:2375-82 (2001)
Reference
PMID:11905738
  Authors
Rintoul RC, Sethi T.
  Title
The role of extracellular matrix in small-cell lung cancer.
  Journal
Lancet Oncol 2:437-42 (2001)
DOI:10.1016/S1470-2045(00)00421-6
Reference
PMID:12243753
  Authors
Ekedahl J, Joseph B, Grigoriev MY, Muller M, Magnusson C, Lewensohn R, Zhivotovsky B.
  Title
Expression of inhibitor of apoptosis proteins in small- and non-small-cell lung carcinoma cells.
  Journal
Exp Cell Res 279:277-90 (2002)
DOI:10.1006/excr.2002.5608
Reference
PMID:12379883
  Authors
Osada H, Takahashi T.
  Title
Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.
  Journal
Oncogene 21:7421-34 (2002)
DOI:10.1038/sj.onc.1205802
Reference
PMID:12741677
  Authors
Yokota J, Nishioka M, Tani M, Kohno T.
  Title
Genetic alterations responsible for metastatic phenotypes of lung cancer cells.
  Journal
Clin Exp Metastasis 20:189-93 (2003)
DOI:10.1023/a:1022978932215
Reference
PMID:16870043
  Authors
Aviel-Ronen S, Blackhall FH, Shepherd FA, Tsao MS.
  Title
K-ras mutations in non-small-cell lung carcinoma: a review.
  Journal
Clin Lung Cancer 8:30-8 (2006)
DOI:10.3816/CLC.2006.n.030
Reference
PMID:15948711
  Authors
Pfeifer GP, Dammann R.
  Title
Methylation of the tumor suppressor gene RASSF1A in human tumors.
  Journal
Biochemistry (Mosc) 70:576-83 (2005)
DOI:10.1007/s10541-005-0151-y
Reference
PMID:11902573
  Authors
Altucci L, Gronemeyer H.
  Title
The promise of retinoids to fight against cancer.
  Journal
Nat Rev Cancer 1:181-93 (2001)
DOI:10.1038/35106036
Reference
PMID:10944551
  Authors
Virmani AK, Rathi A, Zochbauer-Muller S, Sacchi N, Fukuyama Y, Bryant D, Maitra A, Heda S, Fong KM, Thunnissen F, Minna JD, Gazdar AF.
  Title
Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas.
  Journal
J Natl Cancer Inst 92:1303-7 (2000)
DOI:10.1093/jnci/92.16.1303
Reference
PMID:12867060
  Authors
Hirsch FR, Scagliotti GV, Langer CJ, Varella-Garcia M, Franklin WA.
  Title
Epidermal growth factor family of receptors in preneoplasia and lung cancer: perspectives for targeted therapies.
  Journal
Lung Cancer 41 Suppl 1:S29-42 (2003)
DOI:10.1016/S0169-5002(03)00137-5
Reference
PMID:16112428
  Authors
Panani AD, Roussos C.
  Title
Cytogenetic and molecular aspects of lung cancer.
  Journal
Cancer Lett 239:1-9 (2006)
DOI:10.1016/j.canlet.2005.06.030
Reference
PMID:12407699
  Authors
Mitsuuchi Y, Testa JR.
  Title
Cytogenetics and molecular genetics of lung cancer.
  Journal
Am J Med Genet 115:183-8 (2002)
DOI:10.1002/ajmg.10692
Reference
PMID:15942304
  Authors
Breuer RH, Postmus PE, Smit EF.
  Title
Molecular pathology of non-small-cell lung cancer.
  Journal
Respiration 72:313-30 (2005)
DOI:10.1159/000085376
Reference
PMID:11895903
  Authors
Piyathilake CJ, Frost AR, Manne U, Weiss H, Bell WC, Heimburger DC, Grizzle WE.
  Title
Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung.
  Journal
Clin Cancer Res 8:734-44 (2002)
Reference
PMID:16189154
  Authors
Awaya H, Takeshima Y, Furonaka O, Kohno N, Inai K.
  Title
Gene amplification and protein expression of EGFR and HER2 by chromogenic in situ hybridisation and immunohistochemistry in atypical adenomatous hyperplasia and adenocarcinoma of the lung.
  Journal
J Clin Pathol 58:1076-80 (2005)
DOI:10.1136/jcp.2004.025585
Reference
PMID:21193867
  Authors
Lappano R, Maggiolini M
  Title
G protein-coupled receptors: novel targets for drug discovery in cancer.
  Journal
Nat Rev Drug Discov 10:47-60 (2011)
DOI:10.1038/nrd3320
Reference
PMID:24508914
  Authors
O'Hayre M, Degese MS, Gutkind JS
  Title
Novel insights into G protein and G protein-coupled receptor signaling in cancer.
  Journal
Curr Opin Cell Biol 27:126-35 (2014)
DOI:10.1016/j.ceb.2014.01.005
Reference
PMID:17251915
  Authors
Dorsam RT, Gutkind JS
  Title
G-protein-coupled receptors and cancer.
  Journal
Nat Rev Cancer 7:79-94 (2007)
DOI:10.1038/nrc2069
Related
pathway
cfr03320  PPAR signaling pathway
cfr04010  MAPK signaling pathway
cfr04020  Calcium signaling pathway
cfr04024  cAMP signaling pathway
cfr04060  Cytokine-cytokine receptor interaction
cfr04066  HIF-1 signaling pathway
cfr04110  Cell cycle
cfr04115  p53 signaling pathway
cfr04150  mTOR signaling pathway
cfr04151  PI3K-Akt signaling pathway
cfr04210  Apoptosis
cfr04310  Wnt signaling pathway
cfr04330  Notch signaling pathway
cfr04340  Hedgehog signaling pathway
cfr04350  TGF-beta signaling pathway
cfr04370  VEGF signaling pathway
cfr04510  Focal adhesion
cfr04512  ECM-receptor interaction
cfr04520  Adherens junction
cfr04630  JAK-STAT signaling pathway
cfr04915  Estrogen signaling pathway
KO pathway
ko05200   
LinkDB

DBGET integrated database retrieval system